Clinical Trial Update: CCI-779 in Treating Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial of CCI-779 (temsirolimus) in patients with metastatic melanoma, indicating the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• CCI-779 (temsirolimus)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED